Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project.

In multivariable analyses, adjusted for age, gender, eGFR, diabetes, hypertension, myocardial infarction, heart failure, and arrhythmia, but not for baseline plasma calcium, the odds for hypocalcemia were numerically lower in the initiators of novel binders than sodium polystyrene sulfonate initiators, however, did not reach statistical significance [OR 0.71 (95% CI 0.44–1.15) p = 0.14].

also in 111,027 other papers